Lexicon Pharmaceuticals, Inc. LXRX
$2.40
-2.83%
at last close
Market Cap$1.07 billion
P/E Ratio—
Div Yield—
Volume2.70M
52-Week Range
$0.84$2.68
Key Stats
- Today's Range
- $2.38 – $2.49
- 50-Day Range
- $1.80 – $2.68
- 52-Week Range
- $0.84 – $2.68
- Volume
- 2.70 million shs
- Average Volume
- 3.00 million shs
- Market Cap
- $1.07 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 6.12
- Price / Sales
- 25.75
Short Interest
- Short Interest
- 2.42%
- Days to Cover
- 26.05
Financials (TTM)
- Revenue
- $41.47 million
- Net Income
- $-61,117,000
- Net Margin
- -147.38%
- Return on Equity
- -35.02%
- Debt-to-Equity
- —
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Related Stocks
Compare head-to-head: LXRX vs LLY·LXRX vs JNJ·LXRX vs ABBV·LXRX vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.